Long-term use of probiotic-containing yogurts is a safe way to prevent helicobacter pylori: Based on a mongolian gerbil's model

Biochemistry Research International

Volumn , Issue , 2013, Pages

  Kuo, Chao Hung ^a,b   Wang, Sophie S W ^a   Lu, Chien Yu ^a,b   Hu, Huang Ming ^a,b   Kuo, Fu Chen ^c   Weng, Bi Chuang ^a   Wu, Chun Chieh ^a   Liu, Chung Jung ^a   Tsai, Pei Yun ^d   Lee, Tsung Cheng ^e   Chen, Li Wei ^e   Cheng, Kuang Hung ^f   Chang, Lin Li ^g   Wu, Deng Chyang ^a,b,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^e Uni President Co Ltd   (Taiwan)

^f NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890022742     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2013/594561     Document Type: Article

References (40)

1. Watanabe T., Tada M., Nagi H., Sasaki S., Nakao M., Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998 115 3 642 648 2-s2.0-0031714446 (Pubitemid 28397299)
2. Ernst P. B., Gold B. D., The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annual Review of Microbiology 2000 54 615 640 2-s2.0-0033768682 10.1146/annurev.micro.54.1.615
3. Blaser M. J., Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. Journal of Infectious Diseases 1999 179 6 1523 1530 2-s2.0-0033028812 10.1086/314785 (Pubitemid 29246603)
4. Fuller R., Probiotics in human medicine. Gut 1991 32 4 439 442 2-s2.0-0025804332
5. Gill H. S., Guarner F., Probiotics and human health: a clinical perspective. Postgraduate Medical Journal 2004 80 947 516 526 2-s2.0-4644370281 10.1136/pgmj.2003.008664 (Pubitemid 39265294)
6. Wang K.-Y., Li S.-N., Liu C.-S., Perng D.-S., Su Y.-C., Wu D.-C., Jan C.-M., Lai C.-H., Wang T.-N., Wang W.-M., Effects of ingesting Lactobacillus-and Bifidobacterium -containing yogurt in subjects with colonized Helicobacter pylori. American Journal of Clinical Nutrition 2004 80 3 737 741 2-s2.0-4544239866 (Pubitemid 41115540)
7. Sheu B.-S., Wu J.-J., Lo C.-Y., Wu H.-W., Chen J.-H., Lin Y.-S., Lin M.-D., Impact of supplement with Lactobacillus-and Bifidobacterium -containing yogurt on triple therapy for Helicobacter pylori eradication. Alimentary Pharmacology and Therapeutics 2002 16 9 1669 1675 2-s2.0-0036734930 10.1046/j.1365-2036.2002.01335.x
8. Kuo C.-H., Hu A.-M., Tsai P.-Y., Wu I.-C., Yang S.-F., Chang L.-L., Wang J.-Y., Jan C.-M., Wang W.-M., Wu D.-C., Short-term Celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model. World Journal of Gastroenterology 2009 15 39 4907 4914 2-s2.0-73949084373 10.3748/wjg.15.4907
9. Dixon M. F., Genta R. M., Yardley J. H., Correa P., Batts K. P., Dahms B. B., Filipe M. I., Haggitt R. C., Haot J., Hui P. K., Lechago J., Lewin K., Offerhaus J. A., Price A. B., Recavarren S., Riddell R. H., Sipponen P., Solcia E., Stolte M., Watanabe H., Classification and grading of Gastritis: the updated Sydney system. American Journal of Surgical Pathology 1996 20 10 1161 1181 2-s2.0-0013575179 10.1097/00000478-199610000-00001 (Pubitemid 26336840)
10. Yang Y. J., Sheu B. S., Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori -infected children. Helicobacter 2012 17 4 297 304
11. Sheu B.-S., Cheng H.-C., Kao A.-W., Wang S.-T., Yang Y.-J., Yang H.-B., Wu J.-J., Pretreatment with Lactobacillus-and Bifidobacterium -containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. American Journal of Clinical Nutrition 2006 83 4 864 869 2-s2.0-33646693155 (Pubitemid 44713152)
12. Felley C. P., Corthésy-Theulaz I., Blanco Rivero J.-L., Sipponen P., Kaufmann M., Bauerfeind P., Wiesel P. H., Brassart D., Pfeifer A., Blum A. L., Michetti P., Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. European Journal of Gastroenterology and Hepatology 2001 13 1 25 29 2-s2.0-0035140016 10.1097/00042737-200101000-00005 (Pubitemid 32099564)
13. Pantoflickova D., Corthésy-Theulaz I., Dorta G., Stolte M., Isler P., Rochat F., Enslen M., Blum A. L., Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Alimentary Pharmacology and Therapeutics 2003 18 8 805 813 2-s2.0-0142249444 10.1046/j.1365-2036.2003.01675.x (Pubitemid 37323646)
14. Yamaoka Y., Kodama T., Kita M., Imanishi J., Kashima K., Graham D. Y., Relation between clinical presentation, Helicobacter pylori density, interleukin 1 β and 8 production, and cagA status. Gut 1999 45 6 804 811 2-s2.0-0032730542
15. Tokunaga Y., Shirahase H., Hoppou T., Kitaoka A., Tokuka A., Ohsumi K., Density of Helicobacter pylori infection evaluated semiquantitatively in gastric cancer. Journal of Clinical Gastroenterology 2000 31 3 217 221 2-s2.0-0033800697 10.1097/00004836-200010000-00006
16. Michetti P., Dorta G., Wiesel P. H., Brassart D., Verdu E., Herranz M., Felley C., Porta N., Rouvet M., Blum A. L., Corthésy-Theulaz I., Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999 60 3 203 209 2-s2.0-0032930405 10.1159/000007660 (Pubitemid 29221886)
17. Gotteland M., Cruchet S., Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. Journal of Antimicrobial Chemotherapy 2003 51 5 1317 1319 2-s2.0-0038778619 10.1093/jac/dkg227 (Pubitemid 36622096)
18. Linsalata M., Russo F., Berloco P., Caruso M. L., Matteo G. D. I., Cifone M. G., Simone C. D. E., Ierardi E., Di Leo A., The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori -infected gastric mucosa. Helicobacter 2004 9 2 165 172 2-s2.0-1942472434 10.1111/j.1083-4389.2004.00214.x (Pubitemid 38506600)
19. Sakamoto I., Igarashi M., Kimura K., Takagi A., Miwa T., Koga Y., Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. Journal of Antimicrobial Chemotherapy 2001 47 5 709 710 2-s2.0-0035018724 (Pubitemid 32447667)
20. Conway P. L., Kjelleberg S., Protein-mediated adhesion of Lactobacillus fermentum strain 737 to mouse stomach squamous epithelium. Journal of General Microbiology 1989 135 5 1175 1186 2-s2.0-0024381182 (Pubitemid 19135399)
21. Marteau P., Minekus M., Havenaar R., Huis In't Veld J. H. J., Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. Journal of Dairy Science 1997 80 6 1031 1037 2-s2.0-0031158713 (Pubitemid 127447084)
22. Aiba Y., Suzuki N., Kabir A. M. A., Takagi A., Koga Y., Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. American Journal of Gastroenterology 1998 93 11 2097 2101 2-s2.0-0032467484 10.1111/j.1572-0241.1998.00600.x (Pubitemid 29076857)
23. Sgouras D., Maragkoudakis P., Petraki K., Martinez-Gonzalez B., Eriotou E., Michopoulos S., Kalantzopoulos G., Tsakalidou E., Mentis A., In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Applied and Environmental Microbiology 2004 70 1 518 526 2-s2.0-0347760389 10.1128/AEM.70.1.518-526.2004 (Pubitemid 38090245)
24. Coconnier M.-H., Lievin V., Hemery E., Servin A. L., Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Applied and Environmental Microbiology 1998 64 11 4573 4580 2-s2.0-0031765113 (Pubitemid 28538035)
25. Kabir A. M. A., Aiba Y., Takagi A., Kamiya S., Miwa T., Koga Y., Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997 41 1 49 55 2-s2.0-0030802952 (Pubitemid 27351639)
26. Johnson-Henry K. C., Mitchell D. J., Avitzur Y., Galindo-Mata E., Jones N. L., Sherman P. M., Probiotics reduce bacterial colonization and gastric inflammation in H. pylori -infected mice. Digestive Diseases and Sciences 2004 49 7-8 1095 1102 2-s2.0-4444308029 10.1023/B:DDAS.0000037794.02040.c2 (Pubitemid 39178072)
27. Sgouras D. N., Panayotopoulou E. G., Martinez-Gonzalez B., Petraki K., Michopoulos S., Mentis A., Lactobacillus johnsonii La1 attenuates Helicobacter pylori -associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clinical and Diagnostic Laboratory Immunology 2005 12 12 1378 1386 2-s2.0-29144469007 10.1128/CDLI.12.12.1378-1386.2005 (Pubitemid 41814207)
28. Boyle R. J., Robins-Browne R. M., Tang M. L. K., Probiotic use in clinical practice: what are the risks? American Journal of Clinical Nutrition 2006 83 6 1256 1264 2-s2.0-33745628389 (Pubitemid 44713053)
29. Kunz A. N., Noel J. M., Fairchok M. P., Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. Journal of pediatric gastroenterology and nutrition 2004 38 4 457 458 2-s2.0-8644289660
30. Thompson C., Mccarter Y. S., Krause P. J., Herson V. C., Lactobacillus acidophilus sepsis in a neonate. Journal of Perinatology 2001 21 4 258 260 2-s2.0-0034871551 10.1038/sj.jp.7200509 (Pubitemid 32785442)
31. Broughton R. A., Gruber W. C., Haffar A. A. M., Baker C. J., Neonatal meningitis due to Lactobacillus. Pediatric Infectious Disease 1983 2 5 382 384 2-s2.0-0021033778 (Pubitemid 14240458)
32. Perapoch J., Planes A. M., Querol A., López V., Martínez-Bendayán I., Tormo R., Fernández F., Peguero G., Salcedo S., Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. European Journal of Clinical Microbiology and Infectious Diseases 2000 19 6 468 470 2-s2.0-0033925112 (Pubitemid 30458658)
33. Salminen M. K., Rautelin H., Tynkkynen S., Poussa T., Saxelin M., Valtonen V., Järvinen A., Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clinical Infectious Diseases 2004 38 1 62 69 2-s2.0-0347683354 10.1086/380455 (Pubitemid 38045874)
34. Kalima P., Masterton R. G., Roddie P. H., Thomas A. E., Lactobacillus rhamnosus infection in a child following bone marrow transplant. Journal of Infection 1996 32 2 165 167 2-s2.0-0029876389 10.1016/S0163-4453(96)91622-9 (Pubitemid 26131703)
35. Soleman N., Laferl H., Kneifel W., Tucek G., Budschedl E., Weber H., Pichler H., Mayer H. K., How safe is safe? A case of Lactobacillus paracasei ssp. paracasei endocarditis and discussion of the safety of lactic acid bacteria. Scandinavian Journal of Infectious Diseases 2003 35 10 759 762 2-s2.0-0242383158 10.1080/00365540310015872 (Pubitemid 37336906)
36. Salminen M. K., Tynkkynen S., Rautelin H., Saxelin M., Vaara M., Ruutu P., Sarna S., Valtonen V., Järvinen A., Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinical Infectious Diseases 2002 35 10 1155 1160 2-s2.0-0037111629 10.1086/342912 (Pubitemid 35305862)
37. Cats A., Kuipers E. J., Bosschaert M. A. R., Pot R. G. J., Vandenbroucke-Grauls C. M. J. E., Kusters J. G., Effect of frequent consumption of a Lactobacillus casei -containing milk drink in Helicobacter pylori -colonized subjects. Alimentary Pharmacology and Therapeutics 2003 17 3 429 435 2-s2.0-0037325483 10.1046/j.1365-2036.2003.01452.x (Pubitemid 36259406)
38. Gill H. S., Probiotics to enhance anti-infective defences in the gastrointestinal tract. Bailliere's Best Practice and Research in Clinical Gastroenterology 2003 17 5 755 773 2-s2.0-0347353507 10.1016/S1521-6918(03) 00074-X
39. Wendakoon C. N., Thomson A. B. R., Ozimek L., Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion 2002 65 1 16 20 2-s2.0-0036010668 10.1159/000051926 (Pubitemid 34310039)
40. Murosaki S., Muroyama K., Yamamoto Y., Yoshikai Y., Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice. Cancer Immunology Immunotherapy 2000 49 3 157 164 2-s2.0-0033937086 (Pubitemid 30430065)